GLP-1-based therapies for diabetes, obesity and beyond US$ 24.60 Min. order: 1 piece ★★★★★ 4.0 (45 reviews) Sold : Login>>
Once-weekly mazdutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, provided clinically relevant reduction in body weight in Chinese adults with obesity or overweight. Full GLORY-1 trial results: https://nej.md/4koUvaP US$ 26.65 Min. order: 1 piece ★★★★★ 4.6 (23 reviews) Sold : Login>>
Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease US$ 20.49 Min. order: 1 piece ★★★★★ 4.9 (115 reviews) Sold : Login>>
Mazdutide and Tirzepatide: How These Dual-Pathway Weight-Loss Drugs Really Compare US$ 21.48 Min. order: 1 piece ★★★★★ 4.1 (149 reviews) Sold : Login>>
Forest plot of the effect of Mazdutide vs Placebo on the percentage of US$ 22.41 Min. order: 1 piece ★★★★★ 5.0 (176 reviews) Sold : Login>>